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Abstract 
 
  
 
Background: Identification of risk factors within precursor syndromes, such as depression, 
anxiety or substance use disorders (SUD), might help to pinpoint high-risk stages where 
preventive interventions for Bipolar Disorder (BD) could be evaluated. Methods: We 
examined baseline demographic, clinical, quality of life, and temperament measures along 
with risk clusters among 52 young people seeking help for depression, anxiety or SUDs 
without psychosis or BD. The risk clusters included Bipolar At-Risk (BAR) and the 
Bipolarity Index as measures of bipolarity and the Ultra-High Risk assessment for psychosis. 
The participants were followed up for 12 months to identify conversion to BD. Those who 
converted and did not convert to BD were compared using Chi-Square and Mann Whitney U 
tests. Results: The sample was predominantly female (85%) and a majority had prior 
treatment (64%). Four participants converted to BD over the 1-year follow up period. Having 
an alcohol use disorder at baseline (75% vs 8%, 2=14.1, p<0.001) or a family history of SUD 
(67% vs 12.5%, 2=6.0, p=0.01) were associated with development of BD. The sub-threshold 
mania subgroup of BAR criteria was also associated with 12-month BD outcomes. The 
severity of depressive symptoms and cannabis use had high effects sizes of association with 
BD outcomes, without statistical significance. Conclusions and Limitations: The small 
number of conversions limited the power of the study to identify associations with risk factors 
that have previously been reported to predict BD. However, subthreshold affective symptoms 
and SUDs might predict the onset of BD among help-seeking young people with high-
prevalence disorders.  
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Background 
Bipolar disorder (BD) is a leading cause of disability and morbidity (Whiteford et al., 2013). 
Early intervention and prevention efforts might help decrease this morbidity, but such efforts 
require identification of precursor syndromes for BD. Familial high risk (Duffy et al., 2014; 
Egeland et al., 2012) and naturalistic cohort studies (Angst et al., 2005; Fiedorowicz et al., 
2011) indicate that depression and anxiety symptoms might be precursor syndromes for BD. 
A longitudinal relationship is also evident between substance use disorders (SUD) and manic 
and hypomanic symptoms (Henquet et al., 2006; Manwani et al., 2006). The concept of high 
prevalence disorders such as depression, anxiety and SUD being precursor syndromes in 
some cases for lower prevalence syndromes such as BD, has received support in familial 
(Duffy et al., 2014), epidemiological (Beesdo et al., 2009) and clinical populations 
(Fiedorowicz et al., 2011). We prospectively examined factors associated with risk of 
developing BD over 12 months among young people seeking help for current depression, 
anxiety or SUD. 
 
Methods  
Participants: A subsample was selected from a cohort of help-seeking young people aged 15-
25 years attending a tertiary youth mental health service in Melbourne, Australia. For the 
primary study, 70 participants were selected from 559 help-seeking young people attending 
Orygen Youth Health (OYH) on the basis that they did not have threshold (hypo)mania or 
psychosis and consented to research follow up. The details of the selection criteria have 
previously been described (Bechdolf et al., 2014). Of these participants, a sub-group was 
selected on the basis of meeting at-risk criteria for BD (Bipolar At-Risk or BAR) (Bechdolf et 
al., 2010). The BAR criteria were: (i) age between 15 and 25 years; (ii) sub-threshold manic 
symptoms; and (iii) sub-threshold depression in combination with either a) cyclothymic 
features or b) family history of BD. Subthreshold mania was defined as Diagnostic and 
Statistical Manual of Mental Disorders (4th ed.; DSM-IV) criteria for hypomania but for a 
shorter duration (between 2 and 4 days) and at a lower threshold for Criterion B symptoms 
(two associated with elation and three with irritability), and without consideration of criteria 
C through E. Subthreshold depression was defined in line with the criteria for Major 
Depressive Episodes in DSM-IV, but for a shorter duration of 1 week and with a requirement 
for a lower number of primary symptoms (three including the major criteria) and excluding 
criteria B through E. Among the participants followed up for 12 months, the current report 
examines a subgroup of 52 with one or more baseline DSM-IV diagnoses — of major 
depressive disorder (MDD), an anxiety disorder or a substance use disorder using the 
Structured Clinical Interview for DSM-IV Axis I Disorders – Patient Edition (SCID IV-I/P) 
(First et al., 2002). Consistent with the DSM 5 (American Psychiatric Association, 2013), 
substance abuse and dependence was combined as a single diagnosis of SUD. The Melbourne 
Health Human Research Ethics Committee approved the research project [No: 2008.613].   
 
Measures: In addition to the SCID-I/P and the BAR criteria, participants were assessed at 
baseline on dimensional measures of psychopathology including the Young Mania Rating 
Scale (YMRS, Young et al., 1978) as a cross sectional measure of manic symptoms and the 
Montgomery Åsberg Depression Rating Scale (MADRS, Montgomery and Asberg, 1979) and 
the Bipolar Depression Rating Scale (BDRS, Berk et al., 2007) for depressive symptoms. 
Brown scales for Attention Deficit Disorder (ADD)(Brown, 1996) were used as a self-report 
measure of dimensional ADD related pathology. The 69-item version of Temperament 
Evaluation of the Memphis, Pisa, Paris, and San Diego Auto-questionnaire (TEMPS-A, 
Akiskal et al., 2005) was used as a measure of temperament. Family history was assessed 
using the Family Interview for Genetic Studies (Maxwell, 1992). As with the SCID-I/P, the 
substance use diagnoses of dependence and abuse were combined to be a single diagnosis of 
substance use disorder among family members. The Comprehensive Assessment of At-Risk 
Mental States (CAARMS, Yung et al., 2005) was used to identify those at Ultra-High Risk 
(UHR) of transition to psychosis. The Bipolarity Index (BI, Sachs, 2004)) was used as a 
composite measure of bipolar risk in addition to BAR criteria. In addition to the SCID IV-I/P, 
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Additions Severity Index (McLellan et al., 1980) was used to quantify the number of days 
alcohol or cannabis was used in the month prior to baseline assessment. The subjective 
quality of life (QoL) was measured using the Modular System for Quality of Life (MSQoL, 
Pukrop et al., 1999). The socio-demographic details were collected using a proforma devised 
for this purpose. At the completion of the 12 month follow-up, the primary measure of 
conversion to BD was made using the Longitudinal Interval Follow-up Evaluation (LIFE) for 
DSM IV diagnoses (Keller et al., 1997).  
 
Statistical analyses: The differences between the converters and non-convertors to BD were 
examined using chi-square tests for categorical variables and Mann-Whitney U tests for 
continuous variables. Effect sizes were also determined due to the risk of type II error, using 
Odds Ratios (OR) or Area Under the receiver-operating characteristic Curve (AUC). 
Corrections for multiple comparisons were not performed, as this was an exploratory study.  
 
Results  
 
At baseline, the sample was of a mean age of 19.7 years, predominantly female (85%) 
(Table1) and were moderately unwell given 75% (n=39) had a previous suicide attempt, 64% 
(n=33) had previous psychiatric treatment and 32% (n=16) had a previous psychiatric 
hospitalization. At 12-month follow up, four participants (7.7%) had developed BD, all of 
whom were female. With respect to their DSM-IV diagnoses, three developed BD II and one 
developed BD not otherwise specified (NOS). Two of the participants who later developed 
BD II and two who did not develop BD were prescribed SSRIs at baseline. Two of the four 
participants who converted to BD were prescribed an anti-depressant at baseline and two 
were not. There were no significant differences between groups with respect to frequency of 
antidepressant or medication use. None of the participants were prescribed stimulants.  
Baseline predictors of developing BD were having an alcohol use disorder, or having a family 
history of SUD (Table 2). In addition, converters had significantly lower physical health QoL 
(converters M=34.1, SD=7.7, non-converters M=44.5, SD=6.7; U=15.5, p=0.03). 
Examination of the BI and BAR criteria indicated that subthreshold (hypo)manic symptoms 
or episodes were significantly associated with later development of BD. There were 
differences between the groups using the ‘Episode Characteristics’ subscale of BI, which 
measures subthreshold (hypo)manic symptoms, as a continuous measure [converters 
M=5.0,SD=0; nonconverters M=2.4 (SD=2.3); U= 30, p=0.02] and using the subthreshold 
mania subgroup of BAR as a discontinuous measure [converters n=2, 29%; nonconverters 
n=2, 4%; 2=5.0, p=0.03]. Though not statistically significant, the AUC values indicative of 
overall classification ability, was high for severity of depression based on MADRS 
(AUC=0.74, SD=0.16) and BDRS (AUC=0.72,SD=0.13) scores as well as the number of 
days of cannabis consumed in the 30 days prior (AUC= 0.70, SD=0.16) using ASI at baseline 
assessment.  
 
Discussion  
Of the 52 help-seeking young people with depressive, anxiety or substance use disorders, 
development of BD over the following 12 months was predicted by baseline sub-threshold 
manic symptoms, alcohol use disorders, family history of substance use disorders and lower 
physical health QoL.  
 
SUDs among participants and their families in the ‘prodromal’ period of BD could be related 
to BD for a number of reasons. One is that there could be shared genetic and environmental 
vulnerabilities among people with SUDs and BD. Presence of BD among probands was 
associated with a higher prevalence of SUDs among family members in an association study 
(Biederman et al., 2000) while a genome-wide association study has identified shared genes 
of risk between BD and SUD (Johnson et al., 2009). Such shared risk factors may include 
impulsivity and a propensity for risk-taking, which have been associated specifically with 
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persons with bipolar disorder, especially when not taking antipsychotic medication (Reddy et 
al., 2014). A second possibility is that the prevalence of SUDs among converters might 
represent self-medication for sub-threshold symptoms or associated cognitive difficulties. In a 
cross-sectional study, a quarter of individuals who experienced mood symptoms reported 
using drugs or alcohol to self-medicate themselves during their mood episodes, the highest 
being among BDI participants (Bolton et al., 2009). Substance abuse, particularly cannabis 
could also possibly act as a factor associated with onset of mania as indicated by a previous 
prospective study (Baethge et al., 2008) examining the co-occurrence of SUD and BD. 
 
Poorer physical QoL has not been previously noted in at-risk samples to the authors’ 
knowledge. While this could be a chance finding due to the small sample size, it is possible 
that some items in the physical QoL measure represent anergic symptoms of depression. In 
addition to this, the severity of depression measured on MADRS and BDRS in the current 
study had high classificatory ability for BD based on AUC, even though this was not 
statistically significant. Severity of depression has been previously identified to be a risk 
factor for prospective conversion to BD among in and outpatients with MDD (Holma et al., 
2008). The role of sub-threshold manic symptoms across risk clusters such as BAR and BI in 
predicting BD may partly be explained by the relatively selective sampling of participants 
that fulfill the BAR criteria. However, previous studies have indicated a role for subthreshold 
manic symptoms (Fiedorowicz et al., 2011; Tijssen et al., 2010) in predicting BD.  
 
The diverse risk factors also indicate that clusters of risk factors such as BAR could be more 
useful than individual risk factors in predicting onset of BD. Using characteristics such as the 
severity of depression, and the prevalence of alcohol and substance use disorders could 
enhance the predictive abilities of these risk clusters.  
 
Limitations  
The primarily limitation of the study is the small number of conversions, particularly the 
absence of conversions to BD-I.  This might be related to the short duration of follow-up as 
well as the over-representation of women in the baseline sample and among convertors. 
However, the conversion rate per year in the current study is substantially higher than that in 
previous samples (Akiskal et al., 1995; Angst et al., 2005). The possibility of type II error due 
to the small sample size of converters may also explain the lack of association with other 
measures that have previously been associated with onset of BD such as temperament, 
attentional difficulties and family history of BD. In addition, women are over-represented 
both in the intake sample as well as among convertors.  
 
Conclusions  
Larger samples of at-risk participants, screened to identify multiple risk factors with adequate 
power to identify the development of BD, preferably over a longer time period might help 
clarify the specificity and magnitude of the predictive ability of these factors for BD. Among 
a group of help seeking young people with high levels of baseline anxiety, depression, 
attentional difficulties and markers of severity such as previous hospitalization and 
suicidality, other risk factors such as sub-threshold symptoms and SUDs could improve the 
prediction of BD onset.  
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Table 1: Baseline clinical and demographic characteristics (N=52)   
 
Characteristic at Baseline % (N)   Mean (SD) 
Female gender 85% (44)  
Age, in years   19.7 (2.8) 
Educational status1    
Year 10 or less 38% (20)  
Year 11 or 12 56% (29)  
More than year 12   6% (3)  
No history of migration 86% (45)  
Previous medical condition 29% (15)  
Previous suicide attempt 75% (39)  
Previous psychiatric hospitalization 32% (16)  
Current diagnosis    
Major Depressive Disorder 65% (34)  
Anxiety disorder 79% (41)  
Substance Use Disorder 37% (19)  
ADD diagnoses2 75% (39)  
UHR for psychosis 21% (11)  
BAR criteria at baseline  50% (26)  
ADD- Attention Deficit Disorder; UHR- Ultra High Risk Criteria, based on the  
Comprehensive Assessment of At-Risk Mental States, BAR- Bipolar At-Risk  
1
- Enrolled or completed; 2-Based on cut offs of 45 for adults and 60 for adolescents  
using the Brown ADD scale 
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